Novo Nordisk News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

02.10.17	Programme de soutien aux installations sportives et récréatives - phase III - Inauguration d'un terrain à surface synthétique à Maniwaki (PR Newswire)
02.10.17	ZGNX Leaps On Trial Data, NVO Gets It Right The 2nd Time, MNKD On Watch (RTTNews)
29.09.17	Novo Nordisk Receives FDA Approval for Fiasp®, a New Fast-Acting Mealtime Insulin (PR Newswire)
26.09.17	Avis aux médias - L'UMQ dressera un bilan de ses actions sur le transport aérien régional (PR Newswire)
22.09.17	Invitation aux médias - Cabinet du ministre des Forêts, de la Faune et des Parcs (PR Newswire)
22.09.17	Inondations printanières 2017 - Journées de rencontres personnalisées les 28 et 29 septembre pour accompagner les sinistrés de l'arrondissement Pierrefonds-Roxboro (PR Newswire)
12.09.17	MSC Industrial Supply Co. to Webcast Review of 2017 Fiscal Fourth Quarter and Full Year Results (PR Newswire)
06.09.17	MDXG Revises Q3 Outlook, Two Down, One To Go For BLPH, TECH Opens Wallet (RTTNews)
05.09.17	Novo Nordisk announces conclusion of U.S. federal investigation of marketing practices (PR Newswire)
28.08.17	Novo Nordisk : Canada Oks Tresiba, New Basal Insulin For Type 1 And 2 Diabetes (RTTNews)
27.08.17	Novo Nordisk Diabetes Drug Victoza Approved In US To Reduce Cardiovascular Risk (RTTNews)
25.08.17	Victoza® (liraglutide) is approved in the US as the only type 2 diabetes treatment indicated to reduce the risk of three major adverse cardiovascular events (PR Newswire)
16.08.17	Breakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma (PR Newswire)
09.08.17	Novo Nordisk H1 Profit Rises; Raises FY Operating Profit Growth Outlook (RTTNews)
28.07.17	Novo Nordisk Says European Commission Approves Update To Victoza Label (RTTNews)
12.07.17	Novo Nordisk and Glooko advance their digital health collaboration with launch of unique integrated app for improved diabetes management (PR Newswire)
11.07.17	Breakfast Technical Briefing on Drug Makers Stocks -- Synergy Pharma, Novo Nordisk, Pernix Therapeutics, and Depomed (PR Newswire)
05.07.17	Novo Nordisk recalls cartridge holders in certain NovoPen Echo® insulin delivery devices due to potential health risks (PR Newswire)
23.06.17	Novo Nordisk Announces Headline Results Of Semaglutide (RTTNews)
16.06.17	Novo Nordisk : FDA Posts Briefing Materials Prior To FDA Panel On Victoza (RTTNews)
01.06.17	FDA Greenlights Novo Nordisk's Rebinyn, TEVA's HALO Shines, LUCY Walks The Talk (RTTNews)
31.05.17	FDA Approves New Novo Nordisk Treatment for Patients with Hemophilia (PR Newswire)
22.05.17	Technical Reports on Drug Makers Stocks -- Synergy Pharma, Novo Nordisk, Apricus Biosciences, and Sucampo Pharma (PR Newswire)
03.05.17	Novo Nordisk Launches Xultophy® 100/3.6 (insulin degludec and liraglutide injection) in the United States (PR Newswire)
03.05.17	Novo Nordisk Q1 Profit Up 7%; Lowers High End Of FY17 Outlook Range (RTTNews)
24.04.17	Biotech Stocks Facing FDA Decision In May (RTTNews)
05.04.17	Drug Makers Stocks Under Scanner -- Synergy Pharma, Novo Nordisk, Apricus Biosciences, and Sucampo Pharma (PR Newswire)
31.03.17	Novo Nordisk : FDA Posts Materials Prior To Panel Meeting On Nonacog Beta Pegol (RTTNews)
30.03.17	Novo Nordisk Resubmits NDA For Fast-acting Insulin Aspart In US (RTTNews)
24.03.17	Novo Nordisk : CHMP Issues Positive Opinion For EU Label Update For Tresiba (RTTNews)
10.03.17	INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 - NVO (PR Newswire)
01.03.17	How These Healthcare Stocks are Faring? -- Synergy Pharma, Novo Nordisk, Apricus Biosciences, and Sucampo Pharma (PR Newswire)
28.02.17	Novo Nordisk Submits NDA For Semaglutide In Japan - Quick Facts (RTTNews)
22.02.17	NVO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Novo Nordisk A/S and a Lead Plaintiff Deadline of March 13, 2017 (PR Newswire)
09.02.17	Great Place to Work® and Fortune Name Novo Nordisk as one of the country's best workplaces for giving back (PR Newswire)
04.02.17	NOVO NORDISK SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit... (PR Newswire)
04.02.17	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadline - NVO (PR Newswire)
02.02.17	Novo Nordisk FY Net Profit Rises (RTTNews)
27.01.17	SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Novo Nordisk A/S To Contact The Firm Before Lead Plaintiff Deadline (PR Newswire)
20.01.17	Drug Makers Stocks on Investors' Radar -- Synergy Pharma, Novo Nordisk, Sucampo Pharma, and Pernix Therapeutics (PR Newswire)
13.01.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO (PR Newswire)
12.01.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 (PR Newswire)
08.12.16	Drug Makers Stocks Under Scanner -- Novo Nordisk, Synergy Pharma, Pernix Therapeutics, and Apricus Biosciences (PR Newswire)
01.12.16	Biotech Sector Growth Expected Upon Diminishing Concerns Over Drug Pricing (PR Newswire)
30.11.16	Mahindra and IBM to Develop Blockchain Solution for Supply Chain Finance (PR Newswire)
30.11.16	Novo Nordisk Announces Headline Results From DEVOTE Trial (RTTNews)
28.10.16	Novo Nordisk Falls Sharply After Slashing Growth Forecast (RTTNews)
28.10.16	Novo Nordisk 9-Month Profit Rises; Updates FY16 Outlook - Quick Facts (RTTNews)
08.10.16	Novo Nordisk Gets FDA Complete Response Letter For Faster-acting Insulin Aspart (RTTNews)
29.09.16	Novo Nordisk To Reduce Approx. 1,000 Employees - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	76.62	0.39 %	K V
Part Grp Hldg	1’271.50	0.36 %	K V
Holcim	89.08	0.25 %	K V
Logitech Intl	74.82	-0.05 %	K V
Lonza Grp	540.60	-0.15 %	K V
UBS Group	27.82	-1.24 %	K V
Sika	223.10	-1.37 %	K V
Nestle	74.10	-1.49 %	K V
Swiss Re	129.60	-1.78 %	K V
Givaudan	3’961.00	-2.46 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Novo Nordisk (spons. ADRs)

Aktien Top/Flop

Novo Nordisk Peer Group Nachrichten

Meistgelesene Nachrichten